Several lines of evidence indicate that TGF-β pathway signaling is necessary for dopaminergic neuron development and function (Tesseur et al., 2017), and TGF-β1 is correlated with pathology in late-onset Alzheimer’s disease and with MDD susceptibility (Zhang K. et al., 2020). This evidence concerns the gene TGFB1 and Alzheimer disease.